Driving Corporate Affairs Excellence in Pharma: Benchmark Study Reveals Key Strategies and Trends for Success
CHAPEL HILL, N.C.,Oct. 04, 2024/ -- Corporate Affairs and Communications teams in pharmaceutical organizations play a pivotal role in maintaining brand reputation and fostering engagement with internal and external stakeholders. As companies increasingly navigate the complexities of digital and traditional communication platforms, maintaining strategic focus and impact has never been more crucial.
Best Practices, LLC, a leading research and consulting firm, conducted an in-depth benchmarking study with 18 biopharmaceutical companies to identify critical elements driving Corporate Affairs excellence. The study, titled, “Identifying Superior Corporate Affairs and Corporate Communications Capabilities,” delivers actionable insights around department structure, staffing, competencies, and future trends that will shape Corporate Affairs in the years to come.
Our research shows that Corporate Affairs is a cornerstone of strategic communication in the pharma industry. The companies that excel are the ones that continuously adapt to the evolving communication landscape while maintaining a strong focus on brand reputation and stakeholder engagement.
Key topics include:
- Best practices in Corporate Affairs structure and staffing
- Strategic planning for brand reputation and communications
- Trends shaping the future of Corporate Affairs in healthcare
Ready to dive deeper? Download the complimentary report summary to gain deeper insights:
https://www.best-in-class.com/rw388.htm">https://www.best-in-class.com/rw388.htm
Pressed for Time? Watch our video summarythat delves into how leading pharma companies ensure strategic focus while managing their core responsibilities: